Mediliv Medical Centre, Samsun, Turkey.
Department of Obstetrics and Gynecology, McGill University, Montreal, Quebec, Canada; OriginElle Fertility Centre, OriginElle Fertility Clinic and Women's Health Centre, Montreal, Quebec, Canada.
Reprod Biomed Online. 2023 Nov;47(5):103257. doi: 10.1016/j.rbmo.2023.06.012. Epub 2023 Jun 26.
What are the embryonic profiles and oocyte maturation dynamics in patients with tubulin beta eight class VIII (TUBB8) mutations leading to oocyte maturation abnormalities (OMAS), and are pregnancies possible in this population?
A prospective cohort study was undertaken in a private fertility clinic between January 2019 and December 2022. Whole-exome genomic studies (WES) were performed to detect mutation types. In-vitro maturation (IVM) was compared in 18 subjects: nine with TUBB8 mutations, and nine without TUBB8 mutations to act as the control group. The distributions of oocyte maturation and embryonic development profiles were recorded. IVF and IVM outcomes of the 18 cases were evaluated. The primary outcomes were the embryonic profiles and maturation dynamics of oocytes derived from IVF or IVM in women as related to TUBB8 mutations.
Mutations were detected in 52 of 89 (58.4%) women who underwent WES analysis. Twelve TUBB8 mutations were detected in nine women (10.1%) with OMAS. Seven novel TUBB8 mutations were noted. Two pregnancies were obtained in women with c.535 G>A TUBB8 mutations. When comparing IVM outcomes between women with and without TUBB8 mutations, there were no differences in oocyte, embryo or pregnancy parameters (P>0.05 in all cases).
It is clear that further TUBB8 mutations which cause oocyte or embryonic arrest will be detected in future. Although biochemical or ectopic pregnancies may be possible in some of these women, no live births or ongoing pregnancies have been reported to date.
导致卵母细胞成熟异常(OMAS)的微管蛋白βVIII 类(TUBB8)突变患者的胚胎特征和卵母细胞成熟动力学是什么,该人群中是否可能怀孕?
在一家私人生育诊所进行了一项前瞻性队列研究,时间为 2019 年 1 月至 2022 年 12 月。进行了全外显子组基因组研究(WES)以检测突变类型。在 18 名受试者中比较了体外成熟(IVM):9 名患有 TUBB8 突变,9 名无 TUBB8 突变作为对照组。记录卵母细胞成熟和胚胎发育特征的分布。评估 18 例患者的 IVF 和 IVM 结果。主要结局是与 TUBB8 突变相关的来自 IVF 或 IVM 的女性卵母细胞的胚胎特征和成熟动力学。
在接受 WES 分析的 89 名女性中,检测到 52 种突变。在 9 名 OMAS 女性中检测到 12 种 TUBB8 突变。发现了 7 种新的 TUBB8 突变。两名患有 c.535 G>A TUBB8 突变的女性获得了妊娠。当比较 TUBB8 突变女性与无 TUBB8 突变女性的 IVM 结果时,在卵母细胞、胚胎或妊娠参数方面没有差异(所有情况下 P>0.05)。
显然,未来将发现更多导致卵母细胞或胚胎停滞的 TUBB8 突变。尽管这些女性中的一些可能会出现生化或异位妊娠,但迄今为止尚无活产或持续妊娠的报道。